HS-10365/SelpercatinibVarious toxicities

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2000卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54875-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：186 / 186

相关论文

共 8 条

[1] Carboplatin/selpercatinibVarious toxicities
Reactions Weekly, 2024, 2002 (1) : 126 - 126
[2] SelpercatinibVarious toxicities: case report
Reactions Weekly, 2024, 2038 (1) : 301 - 301
[3] Lenvatinib/selpercatinibVarious toxicities: case report
Reactions Weekly, 2023, 1946 (1) : 317 - 317
[4] Cabozantinib/selpercatinibVarious toxicities: case report
Reactions Weekly, 2021, 1850 (1) : 85 - 85
[5] SelpercatinibVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1801 (1) : 231 - 231
[6] Pemetrexed/SelpercatinibVarious toxicities: case report
Reactions Weekly, 2024, 2027 (1) : 423 - 423
[7] HS-10365, a highly potent and selective RET tyrosine kinase inhibitor, demonstrates robust activity in RET fusion positive NSCLC patients
Lu, Shun
Wang, Qiming
Wu, Lin
Xing, Ligang
Li, Yintao
Han, Liang
Dong, Xiaorong
Wei, Hongying
Xu, Wen
Li, Chuan
Yang, Liuqing
Wu, Qiong
CANCER RESEARCH, 2023, 83 (08)
[8] Osimertinib/selpercatinibVarious toxicities and acquired resistance: case report
Reactions Weekly, 2022, 1906 (1) : 322 - 322